Literature DB >> 17371490

A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3.

R Schneppenheim1, G Castaman, A B Federici, W Kreuz, R Marschalek, J Oldenburg, F Oyen, U Budde.   

Abstract

BACKGROUND: Severe von Willebrand disease (VWD) type 3 is caused by large deletions, insertions, small truncating mutations, splice site mutations and missense mutations of the VWF gene, respectively. Large deletions have been regarded as being a rare cause of VWD type 3. Complete gene deletions have only been identified in Italian and German patients to date. However, their extent and breakpoints have not been determined yet.
OBJECTIVES: To identify the breakpoints of complete VWF deletions in patients with VWD type 3. PATIENTS/
METHODS: Five index patients with large deletions from two unrelated German and three Italian families were investigated by polymerase chain reaction (PCR) and primer walking. Haplotypes were composed of eight deletion flanking markers.
RESULTS: After initial characterization of a homozygous 253,246 bp deletion (Delta253 k) in a German patient, with the centromeric breakpoint located between CD9 and VWF and the telomeric breakpoint in intron 3 of TMEM16B, respectively, we identified the same Delta253 k in an additional two homozygous and two compound-heterozygous patients, and in their heterozygous parents. All patients share the same deletion-associated marker haplotype. The genomic structure of the breakpoint regions favors DNA double-strand breaks followed by non-homologous end-joining repair as an underlying molecular mechanism rather than a homologous recombination event.
CONCLUSIONS: Our results suggest a single genetic origin of Delta253 k. Homozygosity for Delta253 k in non-consanguineous families from two different countries may indicate a higher incidence of large deletions in VWD type 3 than previously thought. The availability of a Delta253k-specific assay allows simple and rapid detection of even heterozygous patients and carriers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371490     DOI: 10.1111/j.1538-7836.2007.02460.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  10 in total

1.  Ca2+-activated Cl− currents are dispensable for olfaction.

Authors:  Gwendolyn M Billig; Balázs Pál; Pawel Fidzinski; Thomas J Jentsch
Journal:  Nat Neurosci       Date:  2011-04-24       Impact factor: 24.884

Review 2.  International Union of Basic and Clinical Pharmacology. LXXXV: calcium-activated chloride channels.

Authors:  Fen Huang; Xiuming Wong; Lily Y Jan
Journal:  Pharmacol Rev       Date:  2011-11-16       Impact factor: 25.468

3.  Platelet morphological changes in 2 patients with von Willebrand disease type 3 caused by large homozygous deletions of the von Willebrand factor gene.

Authors:  Paquita Nurden; Alan T Nurden; Silvia La Marca; Margherita Punzo; Luciano Baronciani; Augusto B Federici
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

4.  ANO2 is the cilial calcium-activated chloride channel that may mediate olfactory amplification.

Authors:  Aaron B Stephan; Eleen Y Shum; Sarah Hirsh; Katherine D Cygnar; Johannes Reisert; Haiqing Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-26       Impact factor: 11.205

Review 5.  von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies.

Authors:  Paula D James; David Lillicrap
Journal:  Am J Hematol       Date:  2012-03-03       Impact factor: 10.047

Review 6.  Anoctamins.

Authors:  Karl Kunzelmann; Yuemin Tian; Joana Raquel Martins; Diana Faria; Patthara Kongsuphol; Jiraporn Ousingsawat; Frank Thevenod; Eleni Roussa; Jason Rock; Rainer Schreiber
Journal:  Pflugers Arch       Date:  2011-05-21       Impact factor: 3.657

7.  Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.

Authors:  E Berntorp; B Fuchs; M Makris; R Montgomery; V Flood; J S O'Donnell; A B Federici; D Lillicrap; P James; U Budde; M Morfini; P Petrini; S Austin; C Kannicht; V Jiménez-Yuste; C Lee
Journal:  Haemophilia       Date:  2013-03       Impact factor: 4.287

8.  TMEM16B induces chloride currents activated by calcium in mammalian cells.

Authors:  Simone Pifferi; Michele Dibattista; Anna Menini
Journal:  Pflugers Arch       Date:  2009-05-28       Impact factor: 3.657

9.  Assessment of the olfactory function in Italian patients with type 3 von Willebrand disease caused by a homozygous 253 Kb deletion involving VWF and TMEM16B/ANO2.

Authors:  Valentina Cenedese; Massimo Mezzavilla; Anna Morgan; Renato Marino; Cosimo Pietro Ettorre; Maurizio Margaglione; Paolo Gasparini; Anna Menini
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

10.  Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.

Authors:  Luciano Baronciani; Ian Peake; Reinhard Schneppenheim; Anne Goodeve; Minoo Ahmadinejad; Zahra Badiee; Mohammad-Reza Baghaipour; Olga Benitez; Imre Bodó; Ulrich Budde; Andrea Cairo; Giancarlo Castaman; Peyman Eshghi; Jenny Goudemand; Wolf Hassenpflug; Hamid Hoorfar; Mehran Karimi; Bijan Keikhaei; Riitta Lassila; Frank W G Leebeek; Maria Fernanda Lopez Fernandez; Pier Mannuccio Mannucci; Renato Marino; Nikolas Nikšić; Florian Oyen; Cristina Santoro; Andreas Tiede; Gholamreza Toogeh; Alberto Tosetto; Marc Trossaert; Eva M K Zetterberg; Jeroen Eikenboom; Augusto B Federici; Flora Peyvandi
Journal:  Blood Adv       Date:  2021-08-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.